ATE277618T1 - Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung - Google Patents

Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung

Info

Publication number
ATE277618T1
ATE277618T1 AT00920742T AT00920742T ATE277618T1 AT E277618 T1 ATE277618 T1 AT E277618T1 AT 00920742 T AT00920742 T AT 00920742T AT 00920742 T AT00920742 T AT 00920742T AT E277618 T1 ATE277618 T1 AT E277618T1
Authority
AT
Austria
Prior art keywords
contraception
org
hormone therapy
combined intermittent
combined
Prior art date
Application number
AT00920742T
Other languages
English (en)
Inventor
Bennink Herman Jan Ti Coelingh
Godefridus Hermanus Jo Deckers
Paul Peter Marie Antonius Dols
Everardus Otto Maria Orlemans
Wilhelmus Gerardus Ed Schoonen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE277618T1 publication Critical patent/ATE277618T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT00920742T 1999-04-29 2000-04-25 Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung ATE277618T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201390 1999-04-29
PCT/EP2000/003747 WO2000066129A2 (en) 1999-04-29 2000-04-25 Use of antiprogestagens in combined therapy

Publications (1)

Publication Number Publication Date
ATE277618T1 true ATE277618T1 (de) 2004-10-15

Family

ID=8240174

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00920742T ATE277618T1 (de) 1999-04-29 2000-04-25 Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung

Country Status (22)

Country Link
EP (1) EP1178807B1 (de)
JP (1) JP2002543136A (de)
KR (1) KR20010110807A (de)
CN (1) CN1349405A (de)
AT (1) ATE277618T1 (de)
AU (1) AU771059B2 (de)
BR (1) BR0010070A (de)
CA (1) CA2371635A1 (de)
CZ (1) CZ20013874A3 (de)
DE (1) DE60014358D1 (de)
HK (1) HK1041834A1 (de)
HU (1) HUP0201875A3 (de)
IL (1) IL145940A0 (de)
MX (1) MXPA01010976A (de)
NO (1) NO20015207L (de)
NZ (1) NZ514895A (de)
PL (1) PL351678A1 (de)
RU (1) RU2234321C2 (de)
SK (1) SK15502001A3 (de)
TR (1) TR200103116T2 (de)
WO (1) WO2000066129A2 (de)
ZA (1) ZA200108741B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009017990B4 (de) 2009-04-21 2022-04-07 Valeo Systèmes d'Essuyage Flachwischblatt

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA929315B (en) * 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
RU2127112C1 (ru) * 1992-03-02 1999-03-10 Шеринг Аг Эстроген (прогестин)антипрогестиновый способ пероральной контрацепции и регулирования менструации, фармацевтическая композиция и набор лекарственных средств
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
WO1993021926A1 (en) * 1992-05-06 1993-11-11 Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
ZA935617B (en) * 1992-08-14 1994-03-07 Akzo Nv Antiprogestogen containing contraceptives.
NZ332894A (en) * 1996-06-25 1999-05-28 Akzo Nobel Nv A regimen containing progestogen and/or estrogen with two or more anti-progestogen dosage units

Also Published As

Publication number Publication date
WO2000066129A2 (en) 2000-11-09
JP2002543136A (ja) 2002-12-17
ZA200108741B (en) 2003-07-23
RU2234321C2 (ru) 2004-08-20
KR20010110807A (ko) 2001-12-13
NO20015207D0 (no) 2001-10-25
IL145940A0 (en) 2002-07-25
HUP0201875A2 (en) 2002-10-28
EP1178807A2 (de) 2002-02-13
MXPA01010976A (es) 2002-07-22
AU4120400A (en) 2000-11-17
DE60014358D1 (de) 2004-11-04
EP1178807B1 (de) 2004-09-29
CA2371635A1 (en) 2000-11-09
BR0010070A (pt) 2002-01-15
AU771059B2 (en) 2004-03-11
NO20015207L (no) 2001-10-25
CZ20013874A3 (cs) 2002-06-12
HK1041834A1 (zh) 2002-07-26
TR200103116T2 (tr) 2002-04-22
HUP0201875A3 (en) 2003-10-28
CN1349405A (zh) 2002-05-15
WO2000066129A3 (en) 2001-04-19
SK15502001A3 (sk) 2002-03-05
PL351678A1 (en) 2003-06-02
NZ514895A (en) 2004-06-25

Similar Documents

Publication Publication Date Title
DK2455083T3 (da) Farmaceutisk sammensætning til dermal anvendelse omfattende calcipotriol og betamethason til behandling af psoriasis
FI20115742L (fi) Mometasonifuroaatin käyttö lääkkeen valmistuksessa
FI971776L (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
ATE320436T1 (de) Dimere pyrrolobenzodiazepine
ITRM910922A1 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
NO964527L (no) Blandinger omfattende DNA-ödeleggende midler og P53
DE60043305D1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
IT1285770B1 (it) Composti corticoidei
NO20015790D0 (no) Androstenderivater
ATE182586T1 (de) Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung
GB9907571D0 (en) Compounds
ATE277618T1 (de) Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung
FI925544A7 (fi) Bentsoehappojohdannaisia leukotrieeniin liittyvien sairauksien hoitami seen
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
GB0312566D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
FI952953L (fi) Aineita metabolisten luustosairauksien hoitamiseen
DE59502325D1 (de) Arzneimittelszusammensetzung aus S-Milchsäure und dessen Verwendung
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
ITMI941541A0 (it) Derivati del carbossimetilidenecicloptimmidazolo procedimento di fabbricazione dei derivati e agenti terapeutici che contengono questi composti
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie
ITRM920516A1 (it) Composizione e suo uso per il trattamento terapeutico di affezioni dermatitiche, particolarmente la psoriasi.
ZA914000B (en) Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
IL98276A0 (en) Use of anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
IT1271706B (it) Composizione farmaceutica contenente bromocriptina e suo uso negli- stati di immunodeficienza acquisita

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties